Krensavage Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Krensavage Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.7M	Hold	167,816	–	–	12.41%	3
2025 Q4	$28.5M	Hold	167,816	–	–	10.08%	4
2025 Q3	$22.1M	Buy	167,816 +3,000	+2%	+$360K	9.42%	3
2025 Q2	$17.5M	Buy	164,816 +64,113	+64%	+$6.96M	9.26%	4
2025 Q1	$12.5M	Sell	100,703 -5,100	-5%	-$665K	6.91%	5
2024 Q4	$13M	Sell	105,803 -4,454	-4%	-$525K	7.71%	5
2024 Q3	$12.3M	Buy	110,257 +1,181	+1%	+$129K	6.88%	6
2024 Q2	$11.6M	Buy	109,076 +7,925	+8%	+$871K	5.35%	7
2024 Q1	$12.2M	Buy	101,151 +1,151	+1%	+$141K	5.4%	7
2023 Q4	$12.3M	Buy	+100,000	New	+$12.5M	4.36%	8

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Krensavage Asset Management's JAZZ Position: Q1 2026 in Review

Krensavage Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 167,816 shares worth $31.7M. The position accounts for 12.41% of the portfolio, ranked #3.

Krensavage Asset Management first reported a position in JAZZ in Q4 2023 and has held it in 10 quarters since. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Krensavage Asset Management held 167,816 shares of Jazz Pharmaceuticals worth $31.7M as of Q1 2026.
Krensavage Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up 12.41% of Krensavage Asset Management's portfolio in Q1 2026, its #3 holding.
Krensavage Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Krensavage Asset Management's 13F filing for Q1 2026, filed 15 May 2026.